The impact of the COVID-19 pandemic on adverse events associated with ACEIs and ARBs: a real-world analysis using the FDA adverse event reporting system.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hui,Qiu

第一单位： Central South University Third Xiangya Hospital Center of Clinical Pharmacology, Changsha, Hunan, CN.

作者： Hui,Qiu ^[1] ; Li,He ^[2] ; Jianzhu,Zhou ^[1] ; Zeying,Feng ^[3] ; Ling,Ye ^[4] ; Tong,Li ^[1] ; Xin,Huang ^[1] ; Longjian,Huang ^[5] ; Chengjun,Guo ^[6] ; Shaojun,Chen ^[7] ; Chengxian,Guo ^[1]

作者单位： Central South University Third Xiangya Hospital Center of Clinical Pharmacology, Changsha, Hunan, CN. ^[1] Department of Pediatrics, the Third Xiangya Hospital of Central South University, Changsha, CN. ^[2] Clinical Trial Institution Office, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, CN. ^[3] Department of Clinical Pharmacology, Xiangya Hospital, Central South University, China.;Institute of Clinical Pharmacology, Central South University, China.;Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, China.;National Clinical Research Center for Geriatric Disorders, China. ^[4] Youjiang Medical University for Nationalities, Baise, CN. ^[5] School of Applied Mathematics, Guangdong University of Technology, Guangzhou, CN. ^[6] Department of Medical Oncology, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, CN. ^[7]

关键词 COVID-19 FAERS adverse drug events angiotensin receptor blockers angiotensin-converting enzyme inhibitors

DOI 10.1080/14740338.2025.2465865

PMID 39927493

发布时间 2025-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert opinion on drug safety

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The impact of the COVID-19 pandemic on adverse events associated with ACEIs and ARBs: a real-world analysis using the FDA adverse event reporting system.

Expert opinion on drug safety

相似文献

Expert opinion on drug safety

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The impact of the COVID-19 pandemic on adverse events associated with ACEIs and ARBs: a real-world analysis using the FDA adverse event reporting system.

Expert opinion on drug safety

相似文献

Expert opinion on drug safety

相关期刊

检索历史清除